Home › Funds › BVF INC/IL › OLMA

BVF INC/IL position in OLMA

OLEMA PHARMACEUTICALS INC · Health Care

BVF INC/IL reported holding 5,295,893 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$66.3M, representing 1.69% of its reported portfolio and ranking #18 among its reported holdings. BVF INC/IL has disclosed OLMA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.30M sh
Reported value held$66.25M
Portfolio Weight1.69%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's OLMA position evolved

BVF INC/IL first disclosed a stake in OLMA in Q3 2023 at 9,135,893 shares (US$112.8M). The position peaked in Q4 2025 at 5,295,893 shares, worth US$132.4M. Across 12 filings, BVF INC/IL increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 5,295,893 shares valued at US$66.3M. Notable position changes include a 37% trim in Q4 2024 (shares fell 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.14M $112.83M New
Q4 2023 9.14M $128.18M Hold
Q1 2024 9.14M $103.42M Hold
Q2 2024 9.14M $98.85M Hold
Q3 2024 9.14M $109.08M Hold
Q4 2024 5.72M $33.32M Reduce
Q1 2025 5.30M $19.91M Reduce
Q2 2025 5.30M $22.56M Hold
Q3 2025 5.30M $51.85M Hold
Q4 2025 5.30M $132.40M Hold
Q1 2026 5.30M $78.96M Hold
Q2 2026 5.30M $66.25M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OLMA and 13F data

OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), Siren, L.L.C. (US$60.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OLMA

All OLMA fund holders →

FAQ

How long has BVF INC/IL held OLMA?

BVF INC/IL has disclosed OLMA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BVF INC/IL's current position in OLMA?

As of Q2 2026, BVF INC/IL holds 5.30M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $66.25M, representing 1.69% of its reported portfolio and ranking #18.

Has BVF INC/IL been buying or selling OLMA?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in OLMA. The position peaked in Q4 2025 at 5.30M shares.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, Siren, L.L.C., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.